{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:21:16Z","timestamp":1784809276036,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,26]],"date-time":"2013-09-26T00:00:00Z","timestamp":1380153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Egyptian National Cancer Institute"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jnci.2013.09.002","type":"journal-article","created":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T15:45:17Z","timestamp":1387295117000},"page":"67-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A descriptive study of plasma cell dyscrasias in Egyptian population"],"prefix":"10.1186","volume":"26","author":[{"given":"Neemat M.","family":"Kassem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdy","family":"EL Zawam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba A.","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"EL Nahas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha M.","family":"El Husseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdy Abd","family":"El Azeeim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jnci.2013.09.002_b0160","doi-asserted-by":"crossref","unstructured":"Irene M. Ghobrial, Jacob P. Laubach, Paul G. Richardson, Plasma cell dyscrasias, in: American Society of Hematology Self-Assessment, Program, 2010, pp. 581\u2013604.","DOI":"10.1182\/ash-sap.2010.20"},{"key":"10.1016\/j.jnci.2013.09.002_b0010","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jnci.2013.09.002_b0015","series-title":"Cecil textbook of medicine","first-page":"1426","article-title":"Plasma cell disorders","author":"Rajkumar","year":"2007"},{"key":"10.1016\/j.jnci.2013.09.002_b0020","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis of monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jnci.2013.09.002_b0025","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jnci.2013.09.002_b0030","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma","volume":"356","author":"Kyle","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jnci.2013.09.002_b0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-540-85772-3_2","article-title":"Epidemiology of multiple myeloma","volume":"183","author":"Becker","year":"2011","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.jnci.2013.09.002_b0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5271\/sjweh.782","article-title":"Occupation, pesticide exposure and risk of multiple myeloma","volume":"30","author":"Baris","year":"2004","journal-title":"Scand J Work Environ Health"},{"key":"10.1016\/j.jnci.2013.09.002_b0045","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"International Myeloma Working Group","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jnci.2013.09.002_b0050","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.ejca.2011.01.020","article-title":"Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies","volume":"47","author":"Wallin","year":"2011","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.jnci.2013.09.002_b0055","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.beha.2007.08.001","article-title":"Epidemiology of the plasma-cell disorders","volume":"20","author":"Kyle","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jnci.2013.09.002_b0060","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/cncr.21662","article-title":"Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a phase III multicenter randomized trial","volume":"106","author":"Rifkin","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jnci.2013.09.002_b0065","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1200\/JCO.2005.03.0221","article-title":"Greipp21-phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group","volume":"24","author":"Vincent Rajkumar","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jnci.2013.09.002_b0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jnci.2013.09.002_b0155","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.jnci.2013.09.002_b0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2141.1992.tb06400.x","article-title":"Impact of active and passive exclusions on the results of a clinical trial in multiple myeloma","volume":"80","author":"Hjorth","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jnci.2013.09.002_b0085","unstructured":"Lugui Qiu, Yafei Wang, Peijing Qi, Dehui Zou, Yaozhong Zhao, Junyuan Qi. Clinical epidemiological study on multiple myeloma in China: a 18-year retrospective study in a representative center. Poster Session: Myeloma \u2013 Biology and Pathophysiology, Excluding Therapy Poster II Sunday, 50th ASH annual meeting. December 7, 2008. poster N 2723."},{"key":"10.1016\/j.jnci.2013.09.002_b0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijc.22718","article-title":"Multiple myeloma: a review of the epidemiologic literature","volume":"120","author":"Alexander","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jnci.2013.09.002_b0100","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.ejca.2006.01.065","article-title":"Epidemiology and outcomes research for MGUS, myeloma and amyloidosis","volume":"42","author":"Sirohi","year":"2006","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.jnci.2013.09.002_b0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2141.2004.05207.x","article-title":"A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK","volume":"127","author":"Phekoo","year":"2004","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jnci.2013.09.002_b0110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/ije\/15.3.321","article-title":"Multiple myeloma in Swedish agricultural workers","volume":"15","author":"Steineck","year":"1986","journal-title":"Int J Epidemiol"},{"issue":"7","key":"10.1016\/j.jnci.2013.09.002_b0115","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10552-006-0030-x","article-title":"Risk patterns of multiple myeloma in Los Angeles county, 1972\u20131999 (United States)","volume":"17","author":"Gebregziabher","year":"2006","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jnci.2013.09.002_b0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12185-011-0971-z","article-title":"Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients","volume":"95","author":"Kaya","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jnci.2013.09.002_b0125","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.ejca.2006.01.065","article-title":"Epidemiology and outcomes research for MGUS, myeloma and amyloidosis","volume":"42","author":"Sirohi","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jnci.2013.09.002_b0130","doi-asserted-by":"crossref","first-page":"123a","DOI":"10.1182\/blood.V108.11.403.403","article-title":"Complete remission represents the major surrogate marker of long survival in multiple myeloma","volume":"108","author":"Wang","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jnci.2013.09.002_b0135","first-page":"245","article-title":"VAD regimen as front line therapy in multiple myeloma","volume":"13","author":"Abu Taleb","year":"2001","journal-title":"J Egypt Nat Cancer Inst"},{"key":"10.1016\/j.jnci.2013.09.002_b0140","first-page":"22","article-title":"VAD regimen as initial treatment for multiple myeloma","author":"Ali Mashhadi","year":"2010","journal-title":"IJHOSCR"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110036213000940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110036213000940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T08:08:33Z","timestamp":1597219713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1110036213000940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1110036213000940"],"URL":"https:\/\/doi.org\/10.1016\/j.jnci.2013.09.002","relation":{},"ISSN":["1110-0362"],"issn-type":[{"value":"1110-0362","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A descriptive study of plasma cell dyscrasias in Egyptian population","name":"articletitle","label":"Article Title"},{"value":"Journal of the Egyptian National Cancer Institute","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnci.2013.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}